Federated Hermes’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8.97M | Sell |
1,570,314
-405,852
| -21% | -$1.84M | 0.01% | 710 |
|
|
2026
Q1 | $8.89M | Buy |
1,976,166
+665,575
| +51% | +$3.47M | 0.01% | 672 |
|
|
2025
Q4 | $8.06M | Buy |
1,310,591
+181,053
| +16% | +$1.31M | 0.01% | 687 |
|
|
2025
Q3 | $8.17M | Buy |
1,129,538
+7,205
| +0.6% | +$42.8K | 0.01% | 612 |
|
|
2025
Q2 | $5.96M | Buy |
1,122,333
+1,121,254
| +103,916% | +$6.62M | 0.01% | 686 |
|
|
2025
Q1 | $9.57K | Sell |
1,079
-7,521
| -87% | -$90.3K | ﹤0.01% | 1811 |
|
|
2024
Q4 | $118K | Sell |
8,600
-47,999
| -85% | -$886K | ﹤0.01% | 1558 |
|
|
2024
Q3 | $1.55M | Sell |
56,599
-208
| -0.4% | -$5.63K | ﹤0.01% | 1002 |
|
|
2024
Q2 | $1.39M | Buy |
56,807
+846
| +2% | +$18.6K | ﹤0.01% | 1003 |
|
|
2024
Q1 | $1.19M | Buy |
55,961
+952
| +2% | +$20.5K | ﹤0.01% | 1075 |
|
|
2023
Q4 | $1.05M | Sell |
55,009
-1,533
| -3% | -$26.5K | ﹤0.01% | 1116 |
|
|
2023
Q3 | $907K | Sell |
56,542
-1
| -0% | -$19 | ﹤0.01% | 1147 |
|
|
2023
Q2 | $1.31M | Sell |
56,543
-1,738
| -3% | -$37.9K | ﹤0.01% | 1076 |
|
|
2023
Q1 | $1.35M | Buy |
58,281
+1,781
| +3% | +$36.2K | ﹤0.01% | 1078 |
|
|
2022
Q4 | $820K | Buy |
56,500
+1,047
| +2% | +$19.5K | ﹤0.01% | 1206 |
|
|
2022
Q3 | $1.06M | Sell |
55,453
-21,762
| -28% | -$499K | ﹤0.01% | 1106 |
|
|
2022
Q2 | $1.4M | Sell |
77,215
-34,567
| -31% | -$718K | ﹤0.01% | 1027 |
|
|
2022
Q1 | $2.82M | Sell |
111,782
-10,547
| -9% | -$270K | 0.01% | 937 |
|
|
2021
Q4 | $3.38M | Buy |
122,329
+29,534
| +32% | +$856K | 0.01% | 926 |
|
|
2021
Q3 | $3M | Buy |
92,795
+27,627
| +42% | +$917K | 0.01% | 945 |
|
|
2021
Q2 | $1.99M | Sell |
65,168
-259
| -0.4% | -$7.48K | ﹤0.01% | 1103 |
|
|
2021
Q1 | $1.99M | Sell |
65,427
-6,808
| -9% | -$193K | ﹤0.01% | 1106 |
|
|
2020
Q4 | $1.43M | Sell |
72,235
-679,748
| -90% | -$11M | ﹤0.01% | 1189 |
|
|
2020
Q3 | $9.81M | Sell |
751,983
-609,441
| -45% | -$7.71M | 0.02% | 575 |
|
|
2020
Q2 | $15.4M | Buy |
1,361,424
+584,219
| +75% | +$8.3M | 0.04% | 445 |
|
|
2020
Q1 | $11.1M | Buy |
+777,205
| New | +$16.4M | 0.03% | 447 |
|
|
2019
Q3 | – | Sell |
-122,085
| Closed | -$3.39M | – | 2267 |
|
|
2019
Q2 | $3.39M | Buy |
122,085
+38,570
| +46% | +$1.09M | 0.01% | 907 |
|
|
2019
Q1 | $2.77M | Sell |
83,515
-39,212
| -32% | -$1.19M | 0.01% | 943 |
|
|
2018
Q4 | $3.57M | Sell |
122,727
-105,192
| -46% | -$3.78M | 0.01% | 836 |
|
|
2018
Q3 | $10.5M | Buy |
227,919
+15,993
| +8% | +$711K | 0.02% | 556 |
|
|
2018
Q2 | $7.92M | Buy |
211,926
+115,784
| +120% | +$3.91M | 0.02% | 539 |
|
|
2018
Q1 | $2.84M | Buy |
96,142
+92,478
| +2,524% | +$3.13M | 0.01% | 818 |
|
|
2017
Q4 | $126K | Hold |
3,664
| – | – | ﹤0.01% | 1574 |
|
|
2017
Q3 | $133K | Sell |
3,664
-75
| -2% | -$2.14K | ﹤0.01% | 1548 |
|
|
2017
Q2 | $97K | Hold |
3,739
| – | – | ﹤0.01% | 1595 |
|
|
2017
Q1 | $72K | Hold |
3,739
| – | – | ﹤0.01% | 1594 |
|
|
2016
Q4 | $62K | Sell |
3,739
-66
| -2% | -$1.19K | ﹤0.01% | 1629 |
|
|
2016
Q3 | $78K | Hold |
3,805
| – | – | ﹤0.01% | 1584 |
|
|
2016
Q2 | $116K | Sell |
3,805
-11,291
| -75% | -$392K | ﹤0.01% | 1550 |
|
|
2016
Q1 | $565K | Buy |
15,096
+11,366
| +305% | +$428K | ﹤0.01% | 1252 |
|
|
2015
Q4 | $161K | Buy |
3,730
+2
| +0.1% | +$84 | ﹤0.01% | 1513 |
|
|
2015
Q3 | $140K | Sell |
3,728
-14,814
| -80% | -$526K | ﹤0.01% | 1539 |
|
|
2015
Q2 | $630K | Buy |
18,542
+12,189
| +192% | +$414K | ﹤0.01% | 1275 |
|
|
2015
Q1 | $225K | Sell |
6,353
-40,592
| -86% | -$1.45M | ﹤0.01% | 1491 |
|
|
2014
Q4 | $1.6M | Buy |
46,945
+954
| +2% | +$33.9K | ﹤0.01% | 1041 |
|
|
2014
Q3 | $1.77M | Hold |
45,991
| – | – | 0.01% | 1015 |
|
|
2014
Q2 | $1.79M | Buy |
45,991
+317
| +0.7% | +$11.8K | 0.01% | 999 |
|
|
2014
Q1 | $1.56M | Buy |
45,674
+7
| +0% | +$217 | 0.01% | 1036 |
|
|
2013
Q4 | $958K | Buy |
45,667
+25,730
| +129% | +$651K | ﹤0.01% | 1176 |
|
|
2013
Q3 | $469K | Buy |
19,937
+19,707
| +8,568% | +$560K | ﹤0.01% | 1321 |
|
|
2013
Q2 | $6K | Buy |
+230
| New | +$6.67K | ﹤0.01% | 1677 |
|
Other funds holding MYGN
VPC
Federated Hermes's MYGN Position: Q2 2026 in Review
Federated Hermes reduced its Myriad Genetics (MYGN) stake by 21% in Q2 2026, selling an estimated $1.84M and leaving 1,570,314 shares worth $8.97M. The position accounts for 0.01% of the portfolio, ranked #710.
Federated Hermes first reported a position in MYGN in Q2 2013 and has held it in 51 quarters since. The position peaked at $15.4M in Q2 2020. 196 funds tracked by Wall St. Rank hold MYGN as of Q2 2026.
- Federated Hermes held 1,570,314 shares of Myriad Genetics worth $8.97M as of Q2 2026.
- Federated Hermes sold 405,852 Myriad Genetics shares in Q2 2026, an estimated $1.84M.
- Myriad Genetics made up 0.01% of Federated Hermes's portfolio in Q2 2026, its #710 holding.
- Federated Hermes first reported a position in Myriad Genetics in Q2 2013 and has held it in 51 quarters since.
- Federated Hermes's Myriad Genetics position peaked at $15.4M in Q2 2020.
- 196 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2026.
Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.